Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 150 of 361 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 01/31/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/03
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 11/30/97
End: 04/30/05
Due: 04/30/06
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 09/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 03/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 01/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/02
End: -
Due: -
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/97
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: 08/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 12/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/00
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 09/30/07
End: -
Due: -